| Brain-first versus body-first Parkinson’s disease: a multimodal imaging case-control study J Horsager, KB Andersen, K Knudsen, C Skjærbæk, TD Fedorova, ... Brain 143 (10), 3077-3088, 2020 | 495 | 2020 |
| Prodromal Parkinson disease subtypes—key to understanding heterogeneity D Berg, P Borghammer, SM Fereshtehnejad, S Heinzel, J Horsager, ... Nature Reviews Neurology 17 (6), 349-361, 2021 | 232 | 2021 |
| Neuropathological evidence of body-first vs. brain-first Lewy body disease P Borghammer, J Horsager, K Andersen, N Van Den Berge, A Raunio, ... Neurobiology of disease 161, 105557, 2021 | 99 | 2021 |
| Obeticholic acid improves hepatic bile acid excretion in patients with primary biliary cholangitis K Kjærgaard, K Frisch, M Sørensen, OL Munk, AF Hofmann, J Horsager, ... Journal of Hepatology 74 (1), 58-65, 2021 | 72 | 2021 |
| Clinical and imaging evidence of brain-first and body-first Parkinson's disease J Horsager, K Knudsen, M Sommerauer Neurobiology of disease 164, 105626, 2022 | 66 | 2022 |
| Gastrointestinal dysfunction in Parkinson’s disease C Skjærbæk, K Knudsen, J Horsager, P Borghammer Journal of Clinical Medicine 10 (3), 493, 2021 | 53 | 2021 |
| A postmortem study suggests a revision of the dual-hit hypothesis of Parkinson’s disease P Borghammer, MK Just, J Horsager, C Skjærbæk, A Raunio, EH Kok, ... npj Parkinson's Disease 8 (1), 166, 2022 | 52 | 2022 |
| Prognostic modeling for patients with colorectal liver metastases incorporating FDG PET radiomic features A Rahmim, KP Bak-Fredslund, S Ashrafinia, L Lu, CR Schmidtlein, ... European journal of radiology 113, 101-109, 2019 | 47 | 2019 |
| Asymmetric dopaminergic dysfunction in brain-first versus body-first Parkinson’s disease subtypes K Knudsen, TD Fedorova, J Horsager, KB Andersen, C Skjærbæk, D Berg, ... Journal of Parkinson's Disease 11 (4), 1677-1687, 2021 | 46 | 2021 |
| Reduced Synaptic Density in Patients with Lewy Body Dementia: An [11C]UCB‐J PET Imaging Study KB Andersen, AK Hansen, MF Damholdt, J Horsager, C Skjærbæk, ... Movement disorders 36 (9), 2057-2065, 2021 | 40 | 2021 |
| Microsleep disturbances are associated with noradrenergic dysfunction in Parkinson’s disease CEJ Doppler, JAM Smit, M Hommelsen, A Seger, J Horsager, ... Sleep 44 (8), zsab040, 2021 | 23 | 2021 |
| Vagus nerve cross-sectional area in patients with Parkinson's disease—an ultrasound case-control study J Horsager, U Walter, TD Fedorova, KB Andersen, C Skjærbæk, ... Frontiers in neurology 12, 681413, 2021 | 15 | 2021 |
| Metabolic liver function measured in vivo by dynamic 18F-FDGal PET/CT without arterial blood sampling J Horsager, OL Munk, M Sørensen EJNMMI research 5, 1-6, 2015 | 14 | 2015 |
| Optimal 2-[18F]fluoro-2-deoxy-d-galactose PET/CT protocol for detection of hepatocellular carcinoma J Horsager, K Bak-Fredslund, LP Larsen, GE Villadsen, TV Bogsrud, ... EJNMMI research 6, 1-7, 2016 | 13 | 2016 |
| Synaptic Density and Glucose Consumption in Patients with Lewy Body Diseases: An [11C]UCB‐J and [18F]FDG PET Study KB Andersen, AK Hansen, AC Schacht, J Horsager, H Gottrup, H Klit, ... Movement Disorders 38 (5), 796-805, 2023 | 10 | 2023 |
| In vivo vesicular acetylcholine transporter density in human peripheral organs: an [18F]FEOBV PET/CT study J Horsager, N Okkels, N Van Den Berge, J Jacobsen, A Schact, OL Munk, ... EJNMMI research 12 (1), 17, 2022 | 10 | 2022 |
| Mapping cholinergic synaptic loss in Parkinson’s disease: An [18F] FEOBV PET case-control study J Horsager, N Okkels, AK Hansen, MF Damholdt, KH Andersen, ... Journal of Parkinson's Disease 12 (8), 2493-2506, 2022 | 10 | 2022 |
| Severe cholinergic terminal loss in newly diagnosed dementia with Lewy bodies N Okkels, J Horsager, M Labrador-Espinosa, PL Kjeldsen, MF Damholdt, ... Brain 146 (9), 3690-3704, 2023 | 9 | 2023 |
| Imaging progressive peripheral and central dysfunction in isolated REM sleep behaviour disorder after 3 years of follow-up TD Fedorova, K Knudsen, KB Andersen, J Horsager, C Skjærbæk, ... Parkinsonism & Related Disorders 101, 99-104, 2022 | 8 | 2022 |
| Cardiac 11C-Donepezil Binding Increases With Age in Healthy Humans: Potentially Signifying Sigma-1 Receptor Upregulation J Horsager, TD Fedorova, NVD Berge, MW Klinge, K Knudsen, ... Journal of cardiovascular pharmacology and therapeutics 24 (4), 365-370, 2019 | 8 | 2019 |
